Adult T Cell Leukemia/Lymphoma

general

A peripheral (mature) T-cell neoplasm linked to the human T-cell leukemia virus type 1 (HTLV-1). Adult T-cell leukemia/lymphoma is endemic in several regions of the world, in particular Japan, the Caribbean, and parts of Central Africa.

50

Centers

46

Active Trials

$7.1B

Cancer Funding

Specific Cancer Types(5)

Top Centers for Adult T Cell Leukemia/Lymphoma(50)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
180.3
2
High-Volume Research Center
71.6
3
NCI Clinical
Active Research Program
69.5
4
NCI Comprehensive
Active Research Program
64.1
5
NCI Comprehensive
Active Research Program
64.1
6
NCI Comprehensive
Active Research Program
64.1
7
NCI Comprehensive
Active Research Program
64.1
8
Active Research Program
64.1
9
Active Research Program
64.1
10
BC CancerVancouver, BC
Active Research Program
64.1
11
NCI Comprehensive
Active Research Program
53.2
12
NCI Comprehensive
Active Research Program
50.7
13
NCI Comprehensive
Active Research Program
50.7
14
NCI Comprehensive
Active Research Program
50.7
15
NCI Comprehensive
Active Research Program
50.7
16
NCI Clinical
Active Research Program
50.7
17
Active Research Program
50.7
18
Active Research Program
50.7
19
NCI Comprehensive
35.7
20
NCI Comprehensive
35.7
21
NCI Comprehensive
35.7
2235.7
23
NCI Comprehensive
35.7
24
Cedars-Sinai CancerLos Angeles, CA
35.7
25
NCI Comprehensive
35.7
2635.7
27
NCI Comprehensive
35.7
28
29
NCI Comprehensive
30
31
NCI Comprehensive
32
33
NCI Comprehensive
34
35
36
37
NCI Comprehensive
38
NCI Comprehensive
39
NCI Comprehensive
40
41
NCI Comprehensive
42
43
NCI Comprehensive
44
45
46
47
48
49
50

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →